Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05346588
Other study ID # 202205053
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date September 29, 2022
Est. completion date June 28, 2023

Study information

Verified date November 2023
Source Washington University School of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To evaluate the feasibility of a pragmatic, large scale, comparative effectiveness, randomized evaluation of patient experience of intravenous propofol versus inhaled volatile anesthesia.


Description:

Two-center single-blinded randomized feasibility study, with randomization 1:1 to either propofol TIVA or inhaled volatile general anesthesia for patients who are receiving elective non-cardiac surgery. Patients will be stratified by clinical site with 150 participants per site.


Recruitment information / eligibility

Status Completed
Enrollment 300
Est. completion date June 28, 2023
Est. primary completion date April 16, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - 18 years or older - Undergoing elective non-cardiac surgery expected to last = 60 min requiring general anesthesia, including a tracheal tube or laryngeal mask airway (or similar supra-glottic device) Exclusion Criteria: - Inability to provide informed consent in English - Pregnancy (based on patient report or positive test on the day of surgery) - Surgical procedure requiring general, regional, neuraxial anesthesia administered by an anesthesia clinician (anesthesiologist, CRNA, anesthesiology assistant) occurring within 30 days prior to or planned to occur within 30 days after surgery date - Contraindication to propofol TIVA or inhaled volatile (for example, documented allergy to propofol, history of severe postoperative nausea or vomiting, concern for or history of malignant hyperthermia) - Surgical procedures requiring specific general anesthesia option (for example, TIVA required for neuromonitoring). - Hospital approved, written protocol mandating a particular technique - History of intraoperative awareness during general anesthesia based on patient self-report on the day of consent - Planned postoperative intubation

Study Design


Intervention

Other:
Anesthetic technique Propofol TIVA
Propofol TIVA no inhaled agent
Anesthetic technique inhaled agent
must administer inhaled agent.

Locations

Country Name City State
United States University of Michigan Ann Arbor Michigan
United States Hosptial of the University of Pennsylvania Philadelphia Pennsylvania
United States Washington University School of Medicine Saint Louis Missouri
United States Stanford University Stanford California

Sponsors (5)

Lead Sponsor Collaborator
Washington University School of Medicine Patient-Centered Outcomes Research Institute, Stanford University, University of Michigan, University of Pennsylvania

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Proportion participating Proportion of patients who are approached to participate by the study team and who consent to participate in the study. 8 months
Primary Proportion receiving TIVA Proportion of patients in the propofol TIVA group who receive per protocol treatment (i.e. they receive no inhaled agents as part of their anesthetic). 8 months
Primary Proportion receiving inhaled anesthesia Proportion of patients in the inhaled volatile group who receive per protocol treatment (i.e. they do receive inhaled agents as part of their anesthetic). 8 months
Secondary Completeness of data collection Completeness of data collection (defined as the percentage of instruments or data fields completed with at least 90% of expected forms or relevant fields completed at each time point and with each instrument) 11 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A